← Back to all signals
RESEARCH PAPER ANALYSIS

Risk factors for recurrence in patients with uterine fibroids treated with high-intensity focused ultrasound.

AI interpretation is pending for this paper.

Open original publication →
PMID39973853
JournalTechnology and health care : official journal of the European Society for Engineering and Medicine
Publication Date2024-11-25
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BackgroundUterine fibroids, benign smooth muscle tumors prevalent in the female genital tract, affecting up to 40% of women of childbearing age. High-intensity focused ultrasound (HIFU) has emerged as a promising non-invasive approach for treating uterine fibroids, but some patients may still experience recurrence of uterine fibroids after treatment.ObjectiveThis study aims to explore the risk factors associated with uterine fibroid recurrence following HIFU treatment, and to provide a basis for formulating response measures to prevent uterine fibroid recurrence after surgery in clinical practice.MethodsIn this regression observational study, 120 patients with uterine fibroids who underwent HIFU therapy at our institution from Jan 2018 to Dec 2021 were included as the study subjects. Collect clinical data of all included patients, and follow up for a total of 2 years every 6 menstrual periods with gynecological ultrasound or related examinations after surgery. Univariate and logistic regression analyses were performed to identify risk factors for recurrence in potential uterine fibroid patients receiving HIFU knife treatment.ResultsPatients were divided into a relapse group (n = 27) and a non-relapse group (n = 93) based on recurrence during the follow-up period. The outcome of univariate analysis indicated no statistically significant difference in age, BMI, age at menarche, history of preoperative pregnancy, history of postoperative pregnancy, family history of uterine fibroids, Bcl-2, FSH, LH, E2, PRL, P, and T between the two groups (p > 0.05). Notably, significant differences were observed in fibroid diameter, ER, and PR (p < 0.05). Logistic regression analysis revealed uterine fibroid diameter (OR = 28.032, 6.074 ∼ 129.372), PR (OR = 4.642, 2.382 ∼ 9.049), and ER (OR = 3.435, 1.820 ∼ 6.483) were independent risk factors for uterine fibroid recurrence after HIFU knife treatment. ROC curve analysis showed that the AUC of uterine fibroid recurrence predicted by fibroid diameter, ER, and PR after HIFU knife treatment were 0.791, 0.738, and 0.785, respectively.ConclusionThe diameter, ER, and PR of uterine fibroids are closely related to the recurrence of uterine fibroids after surgical treatment, and it is worth implementing key perioperative management in clinical practice to prevent and manage the recurrence of uterine fibroids.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Retinoblastoma Metastatic to Bone: Case Series and Literature Review. Journal of radiology case reports 53.4 2 Pediatric Plantar Malignant Melanoma, Subungual Melanoma, and Spitzoid Melanoma: A Case Series of Rare Pediatric Melanomas. The Journal of clinical and aesthetic dermatology 48.5 3 Inborn errors of immunity and mortality: 10 years of single-center experience. Allergologia et immunopathologia 60.5 4 Regional Diversity of Human Papillomavirus Genotypes in Southeastern Brazil: Implications for Cervical Cancer Screening. Journal of medical virology 61.0 5 Epidemiology and Survival Determinants of Monomorphic Epitheliotropic T-Cell Lymphoma: A Pooled Patient-Level Dataset Analysis. Hematological oncology 74.52 6 Knowledge, attitudes, and practices regarding Helicobacter pylori-induced gastric ulcers and cancers among Saudi residents: a nationwide web-based survey. Frontiers in public health 70.4 7 Adult psychological outcomes among women with different adolescent PCOS presentations. Frontiers in endocrinology 59.5 8 Computational insights into synergistic mechanisms of PD-901 and 5-azacitidine targeting PTPN11 (SHP2) E76K mutation in juvenile myelomonocytic leukemia. Frontiers in bioinformatics 62.85 9 Clinical evidence and biological mechanisms linking obesity to adverse outcomes in pediatric and adolescent acute lymphoblastic leukemia. Frontiers in oncology 68.95 10 [Comparison of inpatient disease statistics based on two coding rules]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 61.9 11 Serum HMGB3 and PCSK9 Levels as Predictors of Early Treatment Response in Pediatric Mycoplasma pneumoniae Pneumonia: A Single-Center Prospective Cohort Study. International journal of general medicine 79.26 12 Prevalence and penetrance of heritable retinoblastoma in two adult population cohorts: implications for genomic newborn screening. European journal of human genetics : EJHG 65.5 13 A mixed methods study of adolescent and young adult cancer survivors and their utilization of a survivorship clinic: Barriers and facilitators. Journal of cancer survivorship : research and practice 65.9 14 Perinatal Characteristics of Japanese Children With Infantile Hemangioma: A Questionnaire-Based Case-Control Study. The Journal of dermatology 67.0 15 Efficacy of celecoxib and methotrexate-vinblastine regimen in desmoid-type fibromatosis: A retrospective cohort study. Medicine 76.0 16 The safety and efficacy of different anti-tuberculosis regimens containing Lzd for RR/MDR/Pre-XDR-TB patients in China. Medicine 68.2 17 Nursing care of a pediatric patient with anti-NMDAR encephalitis complicated by secondary epilepsy: A case report. Medicine 61.1 18 Cardiac involvement in neurofibromatosis type 1: real-world baseline and follow-up findings from a tertiary single-center cohort. European journal of pediatrics 62.9 19 Multimodal clinical-radiomic-deep learning model for preoperative classification of pediatric pineal region tumors. Neuroradiology 70.4 20 Precision medicine for pediatric gliomas. Current opinion in oncology 80.34 21 Parental distress - a predictor of treatment adherence in pediatric neuroblastoma: a cross-sectional study of chinese families. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 62.24 22 Integrating optimal patient-centered care: patient- and family-reported experiences after complex treatment for rare diseases. World journal of pediatrics : WJP 63.94 23 [Guidelines for the diagnosis and treatment of hemophagocytic lymphohistiocytosis (2026 edition)]. Zhonghua yi xue za zhi 73.84 24 Cranial MRI in Girls With Central Precocious Puberty: Clinical Characteristics and Predictors of Abnormal Findings. Saudi medical journal 69.8 25 Diffuse midline glioma, H3 K27-altered, forming a suprasellar mass: A case report. Radiology case reports 51.9 26 Integrating immunophenotyping and morphology in the diagnosis of acute leukemia at the National Oncology Center, Sana'a, Yemen. The Libyan journal of medicine 61.0 27 Not Just a Pediatric Condition: Down Syndrome Across the Lifespan. Missouri medicine 54.0 28 The incidence of thyroid cancer in Danish children, adolescents and young adults. Danish medical journal 56.0 29 Cancer in Young Women: Late-Stage Breast Cancer Registry Analysis of a 24-Year Nationwide Retrospective Cohort of 52,734 Patients in Brazil (CLARA Study). Clinical breast cancer 71.0 30 Pediatric Familial Cerebral Cavernous Malformation Associated With a Novel KRIT1 Initiation-Region Frameshift Variant. Molecular genetics & genomic medicine 56.0 31 Social Inequalities, Geographical Accessibility to Care, and Excess Mortality for Patients With Hematological Malignancies in France: Results From French Cancer Registries. Hematological oncology 65.2 32 Bibliometric and clinical trial landscape of hepatoblastoma (2000-2024): a multi-database analysis of global research. Frontiers in oncology 77.1
PATIENT-FRIENDLY SUMMARY

Risk factors for recurrence in patients with uterine fibroids treated with high-intensity focused ultrasound.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic